Hydra Biosciences Inc.
Molecular regeneration medicines, and drugs targeting novel ion channels to address unmet medical needs in cardiovascular disease. Hydra is using proprietary assays, genetics, genomics and signal transduction to discover proteins and small molecules that reprogram a patient's own mature cells to become regeneration cells that multiply rapidly to replace damaged or destroyed cells without scarring.
http://www.hydrabiosciences.com
